Mestinon and cardiac arrest Patient Reports February 12, 2012



Mestinon Side Effects Report #5706630-9
Mestinon side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 12, 1998. Male patient, 70 years of age, was diagnosed with myasthenia gravis and was treated with Mestinon. After drug was administered, patient experienced the following side effects: bacterial infection What is  bacterial infection, bronchitis What is  bronchitis, cardiac arrest What is  cardiac arrest, condition aggravated, cyanosis, dyspnoea, hypoxia, myasthenia gravis, obstructive airways disorder. Mestinon dosage: 480 MG; PO. During the same period patient was treated with RETINEC, GLUCOPHAGE, STILNOX, FLAXIPARINE, TEGELINE. Patient recovered.

Mestinon Side Effects Report #4826055-8
Mestinon side effect was reported by a Pharmacist from UNITED STATES on Nov 10, 2005. Male patient, 49 years of age, weighting 168.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest What is  cardiac arrest. Mestinon dosage: 60 MG PO Q6H. Patient recovered.

Mestinon Side Effects Report #5159211-2
Mestinon side effect was reported by a Health Professional from FRANCE on Nov 03, 2006. Male patient, 69 years of age, was diagnosed with muscular weakness and was treated with Mestinon. After drug was administered, patient experienced the following side effects: cardiac arrest What is  cardiac arrest. Mestinon dosage: 60 MG; BID; PO. During the same period patient was treated with IMURAN, EPREX, DALTEPARIN, MEDROL, LANTUS, LASIX, TARDYFERON, DIFFU K. Patient died on 10/10/2006.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Mestinon